Zhenquan Hu

2.1k citations

33 papers · 1.3k indexed · 1 hit paper · h-index 16

Molecular Biology
Organic Chemistry top 10%
Computational Theory and Mathematics top 2%
Pharmacology top 10%
Biotechnology top 5%

Co-authors: Shuguang Yuan H. C. Stephen Chan Qingsong Liu Angelo Vedani Shugeng Cao Martin Smieško Max Dobler Horst Vogel
Topics: Microbial Natural Products and Biosynthesis (8 papers)Chronic Myeloid Leukemia Treatments (7 papers)Fungal Biology and Applications (7 papers)
Cited by: Computational Theory and Mathematics Biotechnology Toxicology
Journals: Angewandte Chemie International Edition Journal of Medicinal Chemistry Molecules
Partner nations: China United States Switzerland

In The Last Decade

Zhenquan Hu

33 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Using PyMOL as a platform for computational drug design

2017 617 citations Shuguang Yuan, H. C. Stephen Chan et al. Wiley Interdisciplinary Reviews Computational Molecular Science profile →

Peers

Countries citing papers authored by Zhenquan Hu

Since Specialization

Citations

This map shows the geographic impact of Zhenquan Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenquan Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenquan Hu more than expected).

Fields of papers citing papers by Zhenquan Hu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenquan Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenquan Hu. The network helps show where Zhenquan Hu may publish in the future.

Co-authorship network of co-authors of Zhenquan Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenquan Hu. A scholar is included among the top collaborators of Zhenquan Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenquan Hu. Zhenquan Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of a highly potent kinase inhibitor capable of overcoming multiple imatinib-resistant ABL mutants for chronic myeloid leukemia (CML) 2021 ·European Journal of Pharmacology ·Tingting Lu,(unknown),Fengming Zou,Xixiang Li,Aoli Wang,Wenliang Wang,Huamin Liang,Qingwang Liu,(unknown),Chen Hu,Cheng Chen,Zhenquan Hu,Wenchao Wang,Lili Li,Jian Ge,Yang Shen,Tao Ren,Jing Liu,Ruixiang Xia,Qingsong Liu	8
2	Secondary Metabolites from the Leather Coral-Derived Fungal Strain Xylaria sp. FM1005 and Their Glycoprotein IIb/IIIa Inhibitory Activity 2021 ·Journal of Natural Products ·(unknown),Jae Hyeon Park,(unknown),Zhenquan Hu,Xiaohua Wu,Hyung Sik Kim,Shugeng Cao	13
3	Aspochalasin H1: A New Cyclic Aspochalasin from Hawaiian Plant-Associated Endophytic Fungus Aspergillus sp. FT1307 2021 ·Molecules ·Mallique Qader,(unknown),Zhenquan Hu,Cong Wang,Xiaohua Wu,Shugeng Cao	7
4	Tryptoquivalines W and X, two new compounds from a Hawaiian fungal strain and their biological activities 2020 ·Tetrahedron Letters ·(unknown),Zhenquan Hu,Xiaohua Wu,Shugeng Cao	12
5	Discovery of (S)-2-(1-(4-Amino-3-(3-fluoro-4-methoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)propyl)-3-cyclopropyl-5-fluoroquinazolin-4(3H)-one (IHMT-PI3Kδ-372) as a Potent and Selective PI3Kδ Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease 2020 ·Journal of Medicinal Chemistry ·Feng Li,Xiaofei Liang,Zongru Jiang,Aoli Wang,Junjie Wang,Cheng Chen,Wenliang Wang,Fengming Zou,Ziping Qi,Qingwang Liu,Zhenquan Hu,(unknown),Hong Wu,Beilei Wang,Li Wang,Jing Liu,(unknown),(unknown)	12
6	Antibacterial kaneoheoic acids A-F from a Hawaiian fungus Fusarium sp. FM701 2020 ·Phytochemistry ·(unknown),Xiaohua Wu,Zhenquan Hu,Wesley Y. Yoshida,Shaobin Hou,Jennifer A. Saito,(unknown),Kirk E. Hevener,John N. Alumasa,Shugeng Cao	9
7	Pharmacologically inhibiting phosphoglycerate kinase 1 for glioma with NG52 2020 ·Acta Pharmacologica Sinica ·Wenliang Wang,Zongru Jiang,Chen Hu,Cheng Chen,Zhenquan Hu,Aoli Wang,Li Wang,Jing Liu,Wenchao Wang,Qingsong Liu	30
8	Discovery of (E)-N-(4-methyl-5-(3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thiazol-2-yl)-2-(4-methylpiperazin-1-yl)acetamide (IHMT-TRK-284) as a novel orally available type II TRK kinase inhibitor capable of overcoming multiple resistant mutants 2020 ·European Journal of Medicinal Chemistry ·Beilei Wang,(unknown),Xuesong Liu,Fengming Zou,Jun‐Jie Wang,Qingwang Liu,Aoli Wang,Zhenquan Hu,Yongfei Chen,(unknown),Zongru Jiang,Cheng Chen,Chen Hu,Li Wang,Wenchao Wang,Qingsong Liu,Jing Liu	15
9	Discovery of 6′-chloro-N-methyl-5’-(phenylsulfonamido)-[3,3′-bipyridine]-5-carboxamide (CHMFL-PI4K-127) as a novel Plasmodium falciparum PI(4)K inhibitor with potent antimalarial activity against both blood and liver stages of Plasmodium 2019 ·European Journal of Medicinal Chemistry ·Xiaofei Liang,Zongru Jiang,Zhenghui Huang,Feng Li,(unknown),Chen Hu,Wenliang Wang,Zhenquan Hu,Qingwang Liu,Beilei Wang,Li Wang,Ziping Qi,Jing Liu,Lubin Jiang,Qingsong Liu	16
10	Repurposing cabozantinib to GISTs: Overcoming multiple imatinib-resistant cKIT mutations including gatekeeper and activation loop mutants in GISTs preclinical models 2019 ·Cancer Letters ·Tingting Lu,Cheng Chen,Aoli Wang,Zongru Jiang,Ziping Qi,Zhenquan Hu,Chen Hu,Feiyang Liu,Wenliang Wang,Wu Hong,Beilei Wang,Li Wang,Shuang Qi,Jiaxin Wu,Wenchao Wang,(unknown),(unknown),Mingfeng Bai,Qingsong Liu,Jing Liu	12
11	Discovery of (E)-N¹-(3-Fluorophenyl)-N³-(3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)malonamide (CHMFL-KIT-033) as a Novel c-KIT T670I Mutant Selective Kinase Inhibitor for Gastrointestinal Stromal Tumors (GISTs) 2019 ·Journal of Medicinal Chemistry ·Xuesong Liu,Beilei Wang,Cheng Chen,Ziping Qi,Fengming Zou,Jun‐Jie Wang,Chen Hu,Aoli Wang,Juan Ge,Qingwang Liu,Kailin Yu,Zhenquan Hu,Zongru Jiang,Wei Wang,Li Wang,Wenchao Wang,Tao Ren,Mingfeng Bai,Qingsong Liu,Jing Liu	16
12	Discovery of 2-(4-Chloro-3-(trifluoromethyl)phenyl)-N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)acetamide (CHMFL-KIT-64) as a Novel Orally Available Potent Inhibitor against Broad-Spectrum Mutants of c-KIT Kinase for Gastrointestinal Stromal Tumors 2019 ·Journal of Medicinal Chemistry ·Yun Wu,Beilei Wang,Junjie Wang,Shuang Qi,Fengming Zou,Ziping Qi,Feiyang Liu,Qingwang Liu,Cheng Chen,Chen Hu,Zhenquan Hu,Aoli Wang,Li Wang,Wenchao Wang,Tao Ren,Yujiao Cai,Mingfeng Bai,Qingsong Liu,Jing Liu	13
13	Discovery of (S)-2-amino-N-(5-(6-chloro-5-(3-methylphenylsulfonamido)pyridin-3-yl)-4-methylthiazol-2-yl)-3-methylbutanamide (CHMFL-PI3KD-317) as a potent and selective phosphoinositide 3-kinase delta (PI3Kδ) inhibitor 2018 ·European Journal of Medicinal Chemistry ·Xiaofei Liang,(unknown),Cheng Chen,Zongru Jiang,Aoli Wang,(unknown),Juan Ge,Zhenquan Hu,Kailin Yu,Wenliang Wang,Fengming Zou,Qingwang Liu,Beilei Wang,Li Wang,Shanchun Zhang,Yuxin Wang,Qingsong Liu,Jing Liu	12
14	Mechanism of host substrate acetylation by a YopJ family effector 2017 ·Nature Plants ·Zhimin Zhang,Ka‐Wai Ma,Linfeng Gao,Zhenquan Hu,Simon Schwizer,Wenbo Ma,Jikui Song	52
15	Using PyMOL as a platform for computational drug designbreakdown → 2017 ·Wiley Interdisciplinary Reviews Computational Molecular Science ·Shuguang Yuan,H. C. Stephen Chan,Zhenquan Hu	617
16	Implementing WebGL and HTML5 in Macromolecular Visualization and Modern Computer-Aided Drug Design 2017 ·Trends in biotechnology ·Shuguang Yuan,H. C. Stephen Chan,Zhenquan Hu	27
17	Discovery of N-(3-(5-((3-acrylamido-4-(morpholine-4-carbonyl)phenyl)amino)-1-methyl-6-oxo-1,6-dihydropyridin-3-yl)-2-methylphenyl)-4-(tert-butyl)benzamide (CHMFL-BTK-01) as a highly selective irreversible Bruton's tyrosine kinase (BTK) inhibitor 2017 ·European Journal of Medicinal Chemistry ·(unknown),Yongfei Chen,Kailin Yu,(unknown),(unknown),Aoli Wang,Wei Wang,Wu Hong,(unknown),Beilei Wang,Li Wang,Zhenquan Hu,Wenchao Wang,Tao Ren,Shanchun Zhang,Qingsong Liu,Cai‐Hong Yun,Jing Liu	18
18	Molecular mechanisms of endocrine and metabolic disruption: An in silico study on antitrypanosomal natural products and some derivatives 2016 ·Toxicology Letters ·Zhenquan Hu,(unknown),Matthias Hamburger,Angelo Vedani	4
19	W246^6.48 Opens a Gate for a Continuous Intrinsic Water Pathway during Activation of the Adenosine A_2A Receptor 2014 ·Angewandte Chemie International Edition ·Shuguang Yuan,Zhenquan Hu,Sławomir Filipek,Horst Vogel	67
20	W246^6.48 Opens a Gate for a Continuous Intrinsic Water Pathway during Activation of the Adenosine A_2A Receptor 2014 ·Angewandte Chemie ·Shuguang Yuan,Zhenquan Hu,Sławomir Filipek,Horst Vogel	14

About Zhenquan Hu

Zhenquan Hu is a scholar working on Hematology, Gastroenterology and Biotechnology, having authored 33 papers that have together received 1.3k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (8 papers), Chronic Myeloid Leukemia Treatments (7 papers) and Fungal Biology and Applications (7 papers). The work is most often cited by research in Computational Theory and Mathematics (224 citations), Biotechnology (114 citations) and Toxicology (33 citations). Zhenquan Hu has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Shuguang Yuan, H. C. Stephen Chan, Qingsong Liu, Angelo Vedani, Shugeng Cao, Martin Smieško, Max Dobler, Horst Vogel, Sławomir Filipek and Jing Liu. Their work appears in journals such as Angewandte Chemie International Edition, Journal of Medicinal Chemistry and Molecules.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact